NCT05120128View on ClinicalTrials.gov

Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day Lenses

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

November 24, 2021

Primary Completion Date

December 13, 2022

Study Completion Date

December 13, 2022

Conditions
Visual Acuity
Interventions
DEVICE

Acuvue® Oasys 1-Day

TEST Lens

Trial Locations (1)

M13 9PL

The University of Manchester, Manchester

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT05120128 - Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day Lenses | Biotech Hunter | Biotech Hunter